Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

OctPM pathway control state

From Bioblast
Revision as of 12:58, 24 January 2016 by Gnaiger Erich (talk | contribs) (Created page with "{{MitoPedia |abbr=PMOct |description='''PGMOct''': Pyruvate & Malate & Octanoylcarnitine. '''MitoPathway control:''' CI<small>&</small>FAO '''SUIT protocol:''' [[SU...")
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)


high-resolution terminology - matching measurements at high-resolution


OctPM pathway control state

Description

PGMOct: Pyruvate & Malate & Octanoylcarnitine.

MitoPathway control: CI&FAO

SUIT protocol: SUIT-RP1, SUIT-RP1

This substrate combination supports CI-linked flux which is typically higher than FAO capacity. In SUIT-RP1, PMOct is induced after PM(E), to evaluate any additive effect of adding Oct. In SUIT-RP2, FAO OXPHOS capacity is measured first, testing for the effect of increasing malate concentration (compare Malate alone, and pyruvate is added to compare FAO as the background state with CI&FAO as the reference state.

Abbreviation: PMOct

Reference: MiPNet21.06 SUIT reference assay



MitoPedia topics: "Respiratory substrate-coupling state" is not in the list (Enzyme, Medium, Inhibitor, Substrate and metabolite, Uncoupler, Sample preparation, Permeabilization agent, EAGLE, MitoGlobal Organizations, MitoGlobal Centres, ...) of allowed values for the "MitoPedia topic" property. Respiratory substrate-coupling state"Respiratory substrate-coupling state" is not in the list (Enzyme, Medium, Inhibitor, Substrate and metabolite, Uncoupler, Sample preparation, Permeabilization agent, EAGLE, MitoGlobal Organizations, MitoGlobal Centres, ...) of allowed values for the "MitoPedia topic" property.